![](/images/general/no_picture/200_user.png)
Jon D Hoffmann
Examiner (ID: 9303, Phone: (571)272-9916 , Office: P/3746 )
Most Active Art Unit | 3746 |
Art Unit(s) | 3746 |
Total Applications | 82 |
Issued Applications | 44 |
Pending Applications | 0 |
Abandoned Applications | 38 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8940543
[patent_doc_number] => 20130190340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'Small-Molecule-Targeted Protein Degradation'
[patent_app_type] => utility
[patent_app_number] => 13/805508
[patent_app_country] => US
[patent_app_date] => 2011-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26202
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13805508
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/805508 | Small-molecule-targeted protein degradation | Jun 29, 2011 | Issued |
Array
(
[id] => 8745402
[patent_doc_number] => 20130085119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-04
[patent_title] => 'AGENT FOR THE TREATMENT OF SKIN CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/520062
[patent_app_country] => US
[patent_app_date] => 2011-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5313
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520062
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/520062 | AGENT FOR THE TREATMENT OF SKIN CONDITIONS | Jun 23, 2011 | Abandoned |
Array
(
[id] => 8767032
[patent_doc_number] => 20130095068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'AGENT FOR TREATING HCV INFECTION'
[patent_app_type] => utility
[patent_app_number] => 13/704221
[patent_app_country] => US
[patent_app_date] => 2011-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10157
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704221
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/704221 | AGENT FOR TREATING HCV INFECTION | Jun 13, 2011 | Abandoned |
Array
(
[id] => 9413706
[patent_doc_number] => 08697743
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-15
[patent_title] => 'Antioxidant camptothecin derivatives and antioxidant antineoplastic nanospheres thereof'
[patent_app_type] => utility
[patent_app_number] => 13/114539
[patent_app_country] => US
[patent_app_date] => 2011-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 23
[patent_no_of_words] => 13106
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13114539
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/114539 | Antioxidant camptothecin derivatives and antioxidant antineoplastic nanospheres thereof | May 23, 2011 | Issued |
Array
(
[id] => 8721289
[patent_doc_number] => 20130072507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'COMBINATION'
[patent_app_type] => utility
[patent_app_number] => 13/698847
[patent_app_country] => US
[patent_app_date] => 2011-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16168
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698847
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/698847 | COMBINATION | May 18, 2011 | Abandoned |
Array
(
[id] => 8756050
[patent_doc_number] => 20130090355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-11
[patent_title] => 'CHEMICAL AGENTS FOR THE PREVENTION OF INHIBITION OR TUMOR METASTASIS'
[patent_app_type] => utility
[patent_app_number] => 13/640596
[patent_app_country] => US
[patent_app_date] => 2011-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5871
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640596
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/640596 | CHEMICAL AGENTS FOR THE PREVENTION OF INHIBITION OR TUMOR METASTASIS | Apr 27, 2011 | Abandoned |
Array
(
[id] => 8697884
[patent_doc_number] => 20130059894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'PESTICIDAL COMPOSITION AND ITS USE'
[patent_app_type] => utility
[patent_app_number] => 13/643575
[patent_app_country] => US
[patent_app_date] => 2011-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3804
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13643575
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/643575 | PESTICIDAL COMPOSITION AND ITS USE | Apr 24, 2011 | Abandoned |
Array
(
[id] => 8453879
[patent_doc_number] => 20120264824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS'
[patent_app_type] => utility
[patent_app_number] => 13/088072
[patent_app_country] => US
[patent_app_date] => 2011-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6202
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13088072
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/088072 | COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | Apr 14, 2011 | Abandoned |
Array
(
[id] => 7561855
[patent_doc_number] => 20110275688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'KETOROLAC COMPOSITIONS FOR CORNEAL WOUND HEALING'
[patent_app_type] => utility
[patent_app_number] => 13/081161
[patent_app_country] => US
[patent_app_date] => 2011-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7124
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20110275688.pdf
[firstpage_image] =>[orig_patent_app_number] => 13081161
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/081161 | KETOROLAC COMPOSITIONS FOR CORNEAL WOUND HEALING | Apr 5, 2011 | Abandoned |
Array
(
[id] => 10892949
[patent_doc_number] => 08916562
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-23
[patent_title] => 'Methods and compositions for safe and effective treatment of telangiectasia'
[patent_app_type] => utility
[patent_app_number] => 13/636463
[patent_app_country] => US
[patent_app_date] => 2011-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8191
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13636463
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/636463 | Methods and compositions for safe and effective treatment of telangiectasia | Mar 24, 2011 | Issued |
Array
(
[id] => 8792734
[patent_doc_number] => 20130109703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'Combination of a GPR119 Agonist and the DPP-IV Inhibitor Linagliptin for Use in the Treatment of Diabetes and Related Conditions'
[patent_app_type] => utility
[patent_app_number] => 13/634886
[patent_app_country] => US
[patent_app_date] => 2011-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19851
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13634886
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/634886 | Combination of a GPR119 Agonist and the DPP-IV Inhibitor Linagliptin for Use in the Treatment of Diabetes and Related Conditions | Mar 17, 2011 | Abandoned |
Array
(
[id] => 8671476
[patent_doc_number] => 20130046014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INCREASED INTRAOCULAR PRESSURE'
[patent_app_type] => utility
[patent_app_number] => 13/581396
[patent_app_country] => US
[patent_app_date] => 2011-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7278
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13581396
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/581396 | Pharmaceutical composition for treatment of increased intraocular pressure | Mar 15, 2011 | Issued |
Array
(
[id] => 8352091
[patent_doc_number] => 08247418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-21
[patent_title] => 'Pyrazine compounds as phosphodiesterase 10 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/042421
[patent_app_country] => US
[patent_app_date] => 2011-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63347
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13042421
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/042421 | Pyrazine compounds as phosphodiesterase 10 inhibitors | Mar 6, 2011 | Issued |
Array
(
[id] => 9427687
[patent_doc_number] => 08703762
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-22
[patent_title] => 'Method of treating organophosphorous poisoning'
[patent_app_type] => utility
[patent_app_number] => 13/027129
[patent_app_country] => US
[patent_app_date] => 2011-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2600
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13027129
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/027129 | Method of treating organophosphorous poisoning | Feb 13, 2011 | Issued |
Array
(
[id] => 8883547
[patent_doc_number] => 20130156731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEAS'
[patent_app_type] => utility
[patent_app_number] => 13/518336
[patent_app_country] => US
[patent_app_date] => 2010-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32571
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13518336
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/518336 | FUSED TRICYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEAS | Dec 19, 2010 | Abandoned |
Array
(
[id] => 5929970
[patent_doc_number] => 20110039929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'MICROBIOLOGICALLY SOUND AND STABLE SOLUTIONS OF GAMMA-HYDROXYBUTYRATE SALT FOR THE TREATMENT OF NARCOLEPSY'
[patent_app_type] => utility
[patent_app_number] => 12/913644
[patent_app_country] => US
[patent_app_date] => 2010-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28740
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039929.pdf
[firstpage_image] =>[orig_patent_app_number] => 12913644
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/913644 | MICROBIOLOGICALLY SOUND AND STABLE SOLUTIONS OF GAMMA-HYDROXYBUTYRATE SALT FOR THE TREATMENT OF NARCOLEPSY | Oct 26, 2010 | Abandoned |
Array
(
[id] => 8797133
[patent_doc_number] => 08436002
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-07
[patent_title] => 'AKT inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/391895
[patent_app_country] => US
[patent_app_date] => 2010-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36302
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13391895
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/391895 | AKT inhibitors | Oct 19, 2010 | Issued |
Array
(
[id] => 8265951
[patent_doc_number] => 20120165377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'AGENT FOR REDUCING VISCERAL FAT WEIGHT'
[patent_app_type] => utility
[patent_app_number] => 13/393164
[patent_app_country] => US
[patent_app_date] => 2010-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5241
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393164
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/393164 | AGENT FOR REDUCING VISCERAL FAT WEIGHT | Sep 26, 2010 | Abandoned |
Array
(
[id] => 9575244
[patent_doc_number] => 08765657
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-01
[patent_title] => 'Antimicrobially effective use solutions comprising combinations of isothiazolones and amines'
[patent_app_type] => utility
[patent_app_number] => 13/394594
[patent_app_country] => US
[patent_app_date] => 2010-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5516
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394594
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/394594 | Antimicrobially effective use solutions comprising combinations of isothiazolones and amines | Sep 21, 2010 | Issued |
Array
(
[id] => 6203010
[patent_doc_number] => 20110065796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'PRODRUGS OF GUANFACINE'
[patent_app_type] => utility
[patent_app_number] => 12/882813
[patent_app_country] => US
[patent_app_date] => 2010-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19201
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065796.pdf
[firstpage_image] =>[orig_patent_app_number] => 12882813
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/882813 | PRODRUGS OF GUANFACINE | Sep 14, 2010 | Abandoned |